AstraZeneca News
Prices
Here are all todays headlines related to AstraZeneca News. If you wish to drill deeper to view past AstraZeneca News items, follow the next 20 headlines link at the foot of the page.
07-07-2020
The Astrazeneca (LON:AZN) share price has risen by 2.76% over the past month and it’s currently trading at 8543. For investors considering whether to buy, hold or sell the stock, the question now is ...
11-05-2020
Bryan Garnier today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 8780p (from 8550p).
30-04-2020
AstraZeneca PLC has achieved a feat that not many companies will manage this year – it maintained its sales and earnings guidance after a strong opening three months. Standout f ...
14-04-2020
AstraZeneca PLC (LON:AZN) rose on Tuesday after announcing trials to assess whether its drug Calquence can be used to treat patients suffering from severe coronavirus effects. Calquence, used for ...
10-04-2020
Circassia Pharma PLC (LON:CIR) has said it is to hand the US rights to two respiratory drugs back to AstraZeneca PLC (LON:AZN) and focus on diagnostics. Astra will waive loans and interest of ...
06-04-2020
StockMarketWire.com - Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 8870p (from 8810p).
17-03-2020
New York, March 17, 2020: The global asthma spacer market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends. Asthma spacers market ...
06-03-2020
The FTSE 100 is down 195 points at 6,510 but even on a day of widescale carnage, there are some bright spots. Pharma stocks are also regarded as defensive investments, which may account for why ...
27-02-2020
The long-term prospects of FTSE 100 shares AstraZeneca plc (LON:AZN) (AZN.L), National Grid plc (LON:NG) (NG.L) and Fresnillo Plc (LON:FRES) (FRES.L) are relatively positive in my opinion. Fresnillo ...
17-02-2020
Barclays set a GBX 8,500 ($111.81) target price on AstraZeneca (LON:AZN) in a research note published on Friday, Borsen Zeitung reports. The brokerage currently has a buy rating on the ...
27-01-2020
AstraZeneca PLC (LON:AZN) is take back the rights to brazikumab, an antibody currently being tested to treat inflammatory bowel diseases such as Crohn’s disease. The drug was licensed to Allergan plc ...
06-01-2020
JP Morgan’s top pick in the big caps was AstraZeneca PLC (LON:AZN), as it is set to launch its Farxiga for heart failure while news on the progress of adjuvant lung cancer candidate Tagrisso and ...
02-01-2020
To keep the lesson grounded in practicality, we'll use ROE to better understand AstraZeneca PLC (LON:AZN). AstraZeneca has a ROE of 14%, based on the last twelve months. That means that for every £1 ...
31-12-2019
“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...
30-12-2019
“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...
20-12-2019
The FTSE 100-listed firm already sold commercial rights in the US in 2017, while now the drugs have lost exclusive rights in most countries in Europe and Africa AstraZeneca PLC (LON:AZN) has agreed to ...
05-12-2019
Analysts said the prevalence of the BRCA-mutated ovarian cancer is higher in China and the approval will boost AstraZeneca’s already strong performance in the region AstraZeneca PLC’s (LON:AZN) ...
03-12-2019
This is part of the Anglo-Swedish giant's focus on its core R&D portfolio and bunch blockbusters it owns As part of its focus on its core drugs portfolio, AstraZeneca PLC (LON:AZN) is divesting the US ...
29-11-2019
Anglo-Swedish drugs giant AstraZeneca PLC (LON:AZN) has been granted a priority review for a new drug’s use in a particularly aggressive and untreated form of lung cancer. Imfinzi, which is already ...
14-11-2019
The application is for the use of selumetinib in children aged three years and older. NF1 is a rare and incurable genetic condition that causes skin abnormalities and non-cancerous tumours AstraZeneca ...
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
| Enter share symbol |
| Search share prices A to Z |
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price